They found higher levels of HO-1 expression both at mRNA and protein levels in Cytarabine (Ara-c) (the main chemotherapy regimen for AML along with Daunorubicin (DNR))-resistant cells compared to Ara-c-sensitive cells. Here, HMOX1 is linked to acute myeloid leukemia.